To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

NCT03195569 · clinicaltrials.gov ↗

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: QL1101
DRUG: Avastin®
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Qilu Pharmaceutical Co., Ltd.

Collaborators

[object Object]